Clinical and Experimental Allergy
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
The effects of a CCR3 inhibitor, AXP1275, on allergen‐induced airway responses in adults with mild‐to‐moderate atopic asthma
2018
-
Myeloid dendritic cells type 2 after allergen inhalation in asthmatic subjects
2014
-
Analytical validation of a novel flow cytometric-based Facilitated Allergen Presentation (FAP) assay as a tool for monitoring allergen-specific immunotherapy
2005
-
Interaction between haemopoietic regulation and airway inflammation
1999
-
CIRCULATING PROGENITORS AND EOSINOPHILS AND LOCAL EOSINOPHILIA IN SEASONAL ALLERGIC RHINITIS
1994
-
Topical Anti-Inflammatory Treatments for Eczema: A Cochrane Systematic Review and Network Meta-Analysis.
2024
-
Impact of Uncontrolled Symptoms on the Health‐Related Quality of Life (EQ‐5D‐5L) of Patients With Allergic Rhinitis: A MASK‐air Study.
54:634-637.
2024
-
Phosphoinositide‐3 kinase activity in severe eosinophilic asthma with recurrent airway infections and neutrophilic exacerbations.
54:428-431.
2024
-
Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
53:1187-1197.
2023
-
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy.
53:610-625.
2023
-
Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review.
53:526-535.
2023
-
Progenitor cell‐derived basophils: A novel barcoded passive degranulation assay in allergic diseases.
53:405-416.
2023
-
Airway autoimmunity, asthma exacerbations, and response to biologics.
52:1365-1378.
2022
-
Information needs of patients considering oral immunotherapy for food allergy.
52:1391-1402.
2022
-
The role of epigenetics in multi‐generational transmission of asthma: An NIAID workshop report‐based narrative review.
52:1264-1275.
2022
-
Individual‐patient data and aggregate evidence syntheses and the future of allergy‐immunology research.
52:598-599.
2022
-
Cannabinoid WIN55212‐2 impairs peanut‐allergic sensitization and promotes the generation of allergen‐specific regulatory T cells.
52:540-549.
2022
-
Limosilactobacillus reuteri DSM‐17938 for preventing cough in adults with mild allergic asthma: A double‐blind randomized placebo‐controlled cross‐over study.
51:1133-1143.
2021
-
A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).
50:1342-1351.
2020
-
A thymic stromal lymphopoietin polymorphism may provide protection from asthma by altering gene expression.
50:471-478.
2020
-
Maternal psychological distress before birth influences gut immunity in mid‐infancy.
50:178-188.
2020
-
Investigating the safety of capsaicin cough challenge in severe asthma.
49:932-934.
2019
-
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study.
49:442-460.
2019
-
Electronic Clinical Decision Support System for allergic rhinitis management: MASK e‐CDSS.
48:1640-1653.
2018
-
Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema.
48:1325-1332.
2018
-
The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.
48:445-451.
2018
-
Patterns of allergic sensitization and atopic dermatitis from 1 to 3 years: Effects on allergic diseases.
48:48-59.
2018
-
Prebiotics for the prevention of allergies: A systematic review and meta‐analysis of randomized controlled trials.
47:1468-1477.
2017
-
Toll‐like receptor‐induced expression of epithelial cytokine receptors on haemopoietic progenitors is altered in allergic asthma.
47:900-908.
2017
-
Glucagon‐like peptide‐1 receptor expression on human eosinophils and its regulation of eosinophil activation.
47:331-338.
2017
-
Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications.
47:161-175.
2017
-
Human bronchial and parenchymal fibroblasts display differences in basal inflammatory phenotype and response to IL‐17A.
46:945-956.
2016
-
Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone‐dependent severe asthma.
46:793-802.
2016
-
Allergen‐induced early and late asthmatic responses to inhaled seasonal and perennial allergens.
45:1647-1653.
2015
-
T regulatory cell phenotypes in peripheral blood and bronchoalveolar lavage from non‐asthmatic and asthmatic subjects.
45:1654-1662.
2015
-
Fel d 1‐derived synthetic peptide immuno‐regulatory epitopes show a long‐term treatment effect in cat allergic subjects.
45:974-981.
2015
-
Infant gut microbiota and food sensitization: associations in the first year of life.
45:632-643.
2015
-
The effects of an epithelial barrier protective cationic aerosol on allergen‐induced airway inflammation in asthma: a randomized, placebo‐controlled clinical trial.
44:1200-1203.
2014
-
Myeloid dendritic cells type 2 after allergen inhalation in asthmatic subjects.
44:921-929.
2014
-
T cell‐mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells.
44:953-964.
2014
-
Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo‐controlled clinical trial.
44:508-516.
2014
-
OX40L blockade and allergen‐induced airway responses in subjects with mild asthma.
44:29-37.
2014
-
Cytokine responses of peripheral blood mononuclear cells to allergen do not identify asthma or asthma phenotypes.
43:1226-1235.
2013
-
Forceps birth delivery, allergic sensitisation and asthma: a population‐based cohort study.
43:332-336.
2013
-
Allergen bronchoprovocation and chitinases in allergic asthma.
43:149-151.
2013
-
The LINA cohort: indoor chemical exposure, circulating eosinophil/basophil (Eo/B) progenitors and early life skin manifestations.
42:1337-1346.
2012
-
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial.
42:1097-1103.
2012
-
Severe asthma: future treatments.
42:706-711.
2012
-
12‐hydroxy‐eicosatetraenoic acid (12‐HETE): a biomarker of Churg‐Strauss syndrome.
42:513-522.
2012
-
Oral immunotherapy for IgE‐mediated cow's milk allergy: a systematic review and meta‐analysis.
42:363-374.
2012
-
Interleukin‐4 and interleukin‐13 prime migrational responses of haemopoietic progenitor cells to stromal cell‐derived factor‐1α.
42:255-264.
2012
-
TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge.
41:1740-1746.
2011
-
Effects of furosemide on allergic asthmatic responses in mice.
41:1456-1467.
2011
-
Allergen inhalation challenge in smoking compared with non-smoking asthmatic subjects.
41:1084-1090.
2011
-
The role of interleukin‐4Rα in the induction of glutamic acid decarboxylase in airway epithelium following acute house dust mite exposure.
40:820-830.
2010
-
Trends and recommendations in studies of mouse airway function.
40:524-527.
2010
-
The definition and diagnosis of Asthma.
39:1652-1658.
2009
-
Haemopoietic processes in allergic disease: eosinophil/basophil development.
39:1297-1306.
2009
-
Human airway smooth muscle promotes eosinophil differentiation.
39:1009-1017.
2009
-
γ‐aminobutyric acid nurtures allergic asthma.
39:956-961.
2009
-
Immunotherapy improves health‐related quality of life of adult patients with dermal reactions following yellow jacket stings.
39:883-889.
2009
-
Provoked models of asthma: what have we learnt?.
39:181-192.
2009
-
Changing of the guard.
39:1-3.
2009
-
Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study.
39:147-158.
2009
-
Of cats and men: immunodominance and the role of HLA‐DP/DQ.
38:1709-1711.
2008
-
Effect of obesity on airway inflammation: a cross‐sectional analysis of body mass index and sputum cell counts.
37:1049-1054.
2007
-
Immunoreactivity profile of peripheral blood mononuclear cells from patients with ragweed‐induced allergic rhinitis.
37:901-908.
2007
-
Effects of inhaled ciclesonide on circulating T‐helper type 1/T‐helper type 2 cells in atopic asthmatics after allergen challenge.
36:1417-1424.
2006
-
Induction of interleukin‐10 and suppressor of cytokine signalling‐3 gene expression following peptide immunotherapy.
36:465-474.
2006
-
Nasal testing for novel anti‐inflammatory agents.
35:981-985.
2005
-
An evaluation of peripheral blood eosinophil/basophil progenitors following nasal allergen challenge in patients with allergic rhinitis.
35:39-44.
2005
-
Fel d 1‐derived T cell peptide therapy induces recruitment of CD4+CD25+; CD4+ interferon‐γ+ T helper type 1 cells to sites of allergen‐induced late‐phase skin reactions in cat‐allergic subjects.
35:52-58.
2005
-
Haemopoietic mechanisms in allergic rhinitis.
35:1-3.
2005
-
Haemopoietic mechanisms in allergic rhinitis..
35:1-3.
2005
-
Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects.
32:818-823.
2002
-
Inhalation of a harmless antigen (ovalbumin) elicits immune activation but divergent immunoglobulin and cytokine activities in mice.
32:411-421.
2002
-
Sputum induction: effect of nebulizer output and inhalation time on cell counts and fluid‐phase measures.
31:1740-1744.
2001
-
Repeatability and validity of cell and fluid‐phase measurements in nasal fluid: a comparison of two methods of nasal lavage.
31:1111-1115.
2001
-
Efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily compared with placebo for the treatment of bilateral polyposis in adults.
30:1460-1468.
2000
-
Effects of once daily dosing with inhaled budesonide on airway hyperresponsiveness and airway inflammation following repeated low‐dose allergen challenge in atopic asthmatics.
30:1235-1243.
2000
-
Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
30:891-899.
2000
-
Changes in interferon‐γ production following specific allergen immunotherapy: biology vs methodology.
30:297-300.
2000
-
Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire.
30:132-140.
2000
-
Allergen isoforms for immunotherapy: diversity, degeneracy and promiscuity.
29:1588-1590.
1999
-
Interleukin‐5 and allergic inflammation.
29:573-575.
1999
-
Adenoviral infection inhibits allergic airways inflammation in mice.
28:1581-1590.
1998
-
Rhinitis management: the patient’s perspective.
28:34-38.
1998
-
Discussion Session B: Early life environmental factors in asthma.
28:50-51.
1998
-
Discussion Session C: The evolution of asthma in childhood.
28:90-91.
1998
-
Discussion Session F: Adult asthma — the twilight years.
28:203-205.
1998
-
Evolution of asthma through childhood.
28:82-89.
1998
-
T-cell responses to house dust mites: bad news for immunotherapy?.
27:853-855.
1997
-
T‐cell responses to house dust mites: bad news for immunotherapy?.
27:853-855.
1997
-
FcεRI expression on monocytes in atopic disease: cause or effect?.
26:616-617.
1996
-
Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid.
25:127-132.
1995
-
Mast cells and the nerves—potential interactions in the context of chronic disease.
25:102-110.
1995
-
Interleukin‐8 is a chemo‐attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects.
23:1027-1036.
1993
-
Atopy in childhood. I. Gender and allergen related risks for development of hay fever and asthma.
23:941-948.
1993
-
Atopy in childhood. II. Relationship to airway responsiveness, hay fever and asthma.
23:949-956.
1993
-
Atopy in childhood. III. Relationship with pulmonary function and airway responsiveness.
23:957-963.
1993
-
A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid.
22:525-532.
1992
-
Basophils, mast cells and eosinophils and their precursors in allergic rhinitis.
21:253-258.
1991
-
Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.
21:77-83.
1991
-
The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors.
20:661-668.
1990
-
The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma.
19:419-424.
1989
-
Basophil mast cell and eosinophil growth and differentiation factors in human allergic disease.
19:249-254.
1989
-
Airway constriction by isocapnic hyperventilation of cold, dry air: comparison of magnitude and duration of protection by nedocromil sodium and sodium cromoglycate.
17:523-528.
1987
-
Effect of beclomethasone dipropionate on nasal metachromatic cell sub‐populations.
16:589-595.
1986
-
Prediction of late asthmatic responses to inhaled allergen.
14:379-385.
1984
-
A double‐blind comparison of ketotifen and disodium cromoglycate in atopic adult asthmatics.
13:253-262.
1983
-
Increased plasma histamine levels in migraine patients.
12:145-149.
1982
-
Effects of oxatomide compared with chlorpheniramine in allergic rhinoconjunctivitis.
11:61-66.
1981
-
Inhibition of allergen‐induced asthma by three forms of sodium cromoglycate.
11:67-77.
1981
-
Serum total IgE in normal subjects and the influence of a family history of allergy.
10:423-431.
1980
-
The use of radioactive isotopes for analysis of cutaneous allergic responses.
10:25-31.
1980
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)